STATCenter·
Ultra-low doses could bring costly cancer treatments to more patients in poorer countries
Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.
Read at STAT →
Low-dose, low-cost immunotherapies may help patients in poorer countries access high-tech cancer treatments.

<iframe src="https://statesidedaily.com/embed/cluster/3ad39342bade01988b8a53e43a67b4f983e418ec" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Ultra-low doses could bring costly cancer treatments to more patients in poorer countries"></iframe>